It’s easy to see how the new Stanford Hospital will look now that the exterior is complete; the interiors are built out; and the furniture, equipment and art are being installed. Less visible but equally important is how the new hospital will feel to patients when it opens this fall.
Multiple teams throughout the hospital have helped create a digitally driven patient experience that matches the majestic façade of the new structure, said Alpa Vyas, vice president of patient experience for Stanford Health Care. “The service and the culture we create inside must complement and enhance the physical environment.”
Digital technology can power personalized, preventive health care
Stanford Medicine is embracing new technologies that allow us to continuously monitor patient health and engage people in programs designed to predict and prevent disease.
Caring for kids using telehealth
Digital health technology is helping Stanford Children’s Health offer patients and their families better access to Stanford Medicine pediatric experts.
A surgeon, educator and inventor builds on collaborations to advance the science of touch.
‘Stanford has saved my life … twice’
Just 28 when she received a new heart at Stanford Hospital in 1991, Yolanda Ishaq went on to become the first heart transplant recipient to have a child at Stanford.
12-year-old’s unique heart surgery
Lizneidy Serratos, a patient at Lucile Packard Children’s Hospital Stanford, became the smallest person in the country to receive a HeartMate 3 ventricular assist device.
New president and CEO for Stanford Children’s Health
Paul King began his new duties on Jan. 28.
A new channel for fun at Packard Children’s
Broadcast programs designed for and featuring patients at Lucile Packard Children’s Hospital Stanford now air from the hospital’s new studio.
The new Stanford Hospital is preparing to open its doors later this year.
A roundup of health-related events in the coming weeks.
"t is going to be lots of work to see how each cancer therapy might cause side effects. We need to study each drug individually.
Michelle Monje, MD, PhD, associate professor of neurology and neurological sciences, on her research into “chemo brain,” the cognitive dysfunction that follows treatment with the cancer drug methotrexate.
Forbes, Dec. 7
This work raises two really important related but separate questions: Do we need opioids, and do we need the procedure?
Alan Schroeder, MD, clinical professor of pediatrics, on his research linking opioid prescriptions from dental providers to an elevated risk for opioid abuse in teenagers and young adults
NBC News, Dec. 3
We’re learning about biology in a way that could help not just one family, but potentially dozens, even hundreds, of families who suffer that same rare condition.
Euan Ashley, MD, professor of medicine at Stanford, on his work with the Undiagnosed Disease Network in diagnosing more than 100 patients afflicted by mysterious illnesses.
GenomeWeb, Oct. 11